Advertisement

Apnex Medical, maker of respiratory devices for patients with sleep disordered breathing, touts a $10 million infusion from New Enterprise Associates.

Apnex Medical logo

Apnex Medical touted a $10 million funding infusion from New Enterprise Associates, planning on using the money to support its ongoing clinical studies.

The St. Paul, Minn.-based respiratory devices company is amid clinical studies for its Hypoglossal Nerve Stimulation System for use in patients with obstructive sleep apnea.

Advertisement
Advertisement